Prevalence of modifiable risk factors in primary elective arthroplasty and their association with infections
DOI:
https://doi.org/10.2340/17453674.2023.8480Keywords:
Arthroplasty, Hip, Infection, Knee, Modifiable risk factors, Periprosthetic joint infection, postoperative complications, Surgical site infection, Total joint arthroplastyAbstract
Background and purpose: The aim of this study was to identify the prevalence of modifiable risk factors of surgical site infections (SSI) in patients undergoing primary elective total joint arthroplasty (TJA) receiving conventional preoperative preparation, and to explore their association with infectious outcomes.
Patients and methods: Information regarding modifiable risk factors (anemia, diabetes, obesity, nutritional status, smoking, physical activity) was prospectively gathered in patients undergoing primary TJA of hip or knee in 2018–2020 at a single institution with 6 weeks’ follow-up time.
Results: 738 patients (median age 68 years [IQR 61–73], women 57%) underwent TJA (knee 64%, hip 36%). Anemia was detected in 8%, diabetes was present in 9%, an additional 2% had undiagnosed diabetes (HbA1c > 47 mmol/mol), and 8% dysglycemia (HbA1c 42–47 mmol/mol). Obesity (BMI ≥ 30) was observed in 52%. Serum albumin, total lymphocyte count, and vitamin D below normal limits was identified in 0.1%, 18%, and 16%, respectively. Current smokers were 7%. Surgical site complications occurred in 116 (16%), superficial SSI in 57 (8%), progressing to periprosthetic joint infection in 7 cases. Univariate analysis identified higher odds of superficial SSI for BMI ≥ 30 (OR 2.1, 95%CI 1.2–3.8) and HbA1c ≥ 42 mmol/mol (OR 2.2, CI 1.1–4.2), but no association was found with other factors.
Conclusion: In a general population undergoing primary TJA an association was found between obesity (52%) and dysglycemia/diabetes (19%) and superficial SSI (8%), which progressed to PJI in 12% of cases, generating a 1% total rate of PJI. Modification of these risk factors might mitigate infectious adverse outcomes.
Downloads
References
Eriksson H K, Lazarinis S. Patient-related factors associated with superficial surgical site infection and progression to a periprosthetic joint infection after elective primary total joint arthroplasty: a single-centre, retrospective study in Sweden. BMJ Open 2022; 12: e060754. doi: 10.1136/bmjopen-2022-060754. DOI: https://doi.org/10.1136/bmjopen-2022-060754
Gallo J, Nieslanikova E. Prevention of prosthetic joint infection: from traditional approaches towards quality improvement and data mining. J Clin Med 2020; 9. doi: 10.3390/jcm9072190. DOI: https://doi.org/10.3390/jcm9072190
Eka A, Chen A F. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee. Ann Transl Med 2015; 3: 233. doi: 10.3978/j.issn.2305-5839.2015.09.26.
Wan S, Sparring V, Cabrales D A, Jansson K, Wikman A. Clinical and budget impact of treating preoperative anemia in major orthopedic surgery: a retrospective observational study. J Arthroplasty 2020; 35: 3084-8. doi: 10.1016/j.arth.2020.06.018. DOI: https://doi.org/10.1016/j.arth.2020.06.018
Shohat N, Muhsen K, Gilat R, Rondon A J, Chen AF, Parvizi J. Inadequate glycemic control is associated with increased surgical site infection in total joint arthroplasty: a systematic review and meta-analysis. J Arthroplasty 2018; 33: 2312-21.e2313. doi: 10.1016/j.arth.2018.02.020. DOI: https://doi.org/10.1016/j.arth.2018.02.020
Citak M, Toussaint B, Abdelaziz H, Klebig F, Dobinsky A, Gebauer M, et al. Elevated HbA1c is not a risk factor for wound complications following total joint arthroplasty: a prospective study. Hip Int 2020; 30: 19-25. doi: 10.1177/1120700020926986. DOI: https://doi.org/10.1177/1120700020926986
Jämsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 2012; 94: e101. doi: 10.2106/jbjs.J.01935. DOI: https://doi.org/10.2106/JBJS.J.01935
Singh J A, Yu S, Chen L, Cleveland J D. Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. J Rheumatol 2019; 46: 1134-40. doi: 10.3899/jrheum.170990. DOI: https://doi.org/10.3899/jrheum.170990
Cross M B, Yi P H, Thomas C F, Garcia J, Della Valle C J. Evaluation of malnutrition in orthopaedic surgery. J Am Acad Orthop Surg 2014; 22: 193-9. doi: 10.5435/jaaos-22-03-193. DOI: https://doi.org/10.5435/JAAOS-22-03-193
Chan V W, Chan P K, Fu H, Cheung M H, Cheung A, Yan C H, et al. Preoperative optimization to prevent periprosthetic joint infection in atrisk patients. J Orthop Surg (Hong Kong) 2020; 28: 2309499020947207. doi: 10.1177/2309499020947207. DOI: https://doi.org/10.1177/2309499020947207
Moyer R, Ikert K, Long K, Marsh J. The value of preoperative exercise and education for patients undergoing total hip and knee arthroplasty: a systematic review and meta-analysis. JBJS Rev 2017; 5: e2. doi: 10.2106/jbjs.Rvw.17.00015. DOI: https://doi.org/10.2106/JBJS.RVW.17.00015
WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1), http://www.who.int/vmnis/indicators/haemoglobin.pdf.2011. Available from: (Accessed November 22, 2022).
World Health Organization—Europe. A healthy lifestyle: WHO recommendations. 2010. Available from: https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations (Accessed November 22, 2022),
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020; 74: 1498-513. doi:10.1038/s41430-020-0558-y. DOI: https://doi.org/10.1038/s41430-020-0558-y
Swedish Professional Associations for Physical Activity. Physical activity in the prevention and treatment of disease. 2021. Available from: https://www.fyss.se/in-english/ (Accessed November 22, 2022).
National Healthcare Safety Network. Centers for Disease Control and Prevention. Surgical site infection event (SSI). 2022. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf (Accessed November 22, 2022).
Parvizi J, Tan T L, Goswami K, Higuera C, Della Valle C, Chen A F, et al. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty 2018; 33: 1309-14.e1302. doi: 10.1016/j.arth.2018.02.078. DOI: https://doi.org/10.1016/j.arth.2018.02.078
ICM-Philly. 2nd International Consensus Meeting (ICM) on Musculoskeletal Infection 2018. Hip & Knee 2018. Available from: https://icmphilly.com/hip-knee/ (Accessed November 22, 2022).
Lübbeke A, Silman A J, Barea C, Prieto-Alhambra D, Carr A J. Mapping existing hip and knee replacement registries in Europe. Health Policy 2018; 122: 548-57. doi: 10.1016/j.healthpol.2018.03.010. DOI: https://doi.org/10.1016/j.healthpol.2018.03.010
Memtsoudis S G, Cozowicz C, Bekeris J, Bekere D, Liu J, Soffin E M, et al. Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis. Br J Anaesth 2019; 123: 269-87. doi: 10.1016/j.bja.2019.05.042. DOI: https://doi.org/10.1016/j.bja.2019.05.042
Pempe C, Werdehausen R, Pieroh P, Federbusch M, Petros S, Henschler R, et al. Predictors for blood loss and transfusion frequency to guide blood saving programs in primary knee- and hip-arthroplasty. Sci Rep 2021; 11: 4386. doi: 10.1038/s41598-021-82779-z. DOI: https://doi.org/10.1038/s41598-021-82779-z
International Diabetes Federation—Iceland. 2022. Available from: https://idf.org/our-network/regions-members/europe/members/139-iceland.html (Accessed November 22, 2022).
McVey L C, Kane N, Murray H, Meek R D, Ahmed S F. Elective hip arthroplasty rates and related complications in people with diabetes mellitus. Hip Int 2022; 32(6): 717-23. doi: 10.1177/1120700020981573. DOI: https://doi.org/10.1177/1120700020981573
Shohat N, Goswami K, Tarabichi M, Sterbis E, Tan T L, Parvizi J. All patients should be screened for diabetes before total joint arthroplasty. J Arthroplasty 2018; 33: 2057-61. doi: 10.1016/j.arth.2018.02.047. DOI: https://doi.org/10.1016/j.arth.2018.02.047
Katakam A, Collins A K, Sauder N, Shin D, Bragdon C R, Chen A F, et al. Obesity increases risk of failure to achieve the 1-year PROMIS PF-10a minimal clinically important difference following total joint arthroplasty. J Arthroplasty 2021; 36: S184-s191. doi: 10.1016/j.arth.2020.11.004. DOI: https://doi.org/10.1016/j.arth.2020.11.004
Iannotti F, Prati P, Fidanza A, Iorio R, Ferretti A, Pèrez Prieto D, et al. Prevention of periprosthetic joint infection (PJI): a clinical practice protocol in high-risk patients. Trop Med Infect Dis 2020; 5. doi: 10.3390/tropicalmed5040186. DOI: https://doi.org/10.3390/tropicalmed5040186
Iceland Directorate of Health. Tóbaksnotkun - tölur. 2021. Available from: https://www.landlaeknir.is/tolfraedi-og-rannsoknir/tolfraedi/heilsa-og-lidan/tobaksnotkun/ (Accessed November 22, 2022).
Anatone A J, Shah R P, Jennings E L, Geller J A, Cooper H J. A riskstratification algorithm to reduce superficial surgical site complications in primary hip and knee arthroplasty. Arthroplast Today 2018; 4: 493-8. doi: 10.1016/j.artd.2018.09.004. DOI: https://doi.org/10.1016/j.artd.2018.09.004
Mistry J B, Naqvi A, Chughtai M, Gwam C, Thomas M, Higuera C A, et al. Decreasing the incidence of surgical-site infections after total joint arthroplasty. Am J Orthop (Belle Mead NJ) 2017; 46: E374-e387.
Thompson O, W-Dahl A, Lindgren V, Gordon M, Robertsson O, Stefánsdóttir A. Similar periprosthetic joint infection rates after and before a national infection control program: a study of 45,438 primary total knee arthroplasties. Acta Orthop 2022; 93: 3-10. doi: 10.1080/17453674.2021.1977532. DOI: https://doi.org/10.1080/17453674.2021.1977532
Additional Files
Published
How to Cite
License
Copyright (c) 2023 Maria Sigurdardottir, Martin Ingi Sigurdsson, Yngvi Olafsson, Solveig H Sverrisdottir, Ingibjorg Gunnarsdottir, Emil L Sigurdsson, Sigurbergur Karason
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
